Cargando…

Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development

BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop n...

Descripción completa

Detalles Bibliográficos
Autores principales: Belyi, Yury, Rybolovlev, Ivan, Polyakov, Nikita, Chernikova, Alena, Tabakova, Irina, Gintsburg, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944129/
https://www.ncbi.nlm.nih.gov/pubmed/29785216
http://dx.doi.org/10.2174/1874285801812010094
_version_ 1783321767763247104
author Belyi, Yury
Rybolovlev, Ivan
Polyakov, Nikita
Chernikova, Alena
Tabakova, Irina
Gintsburg, Alexandre
author_facet Belyi, Yury
Rybolovlev, Ivan
Polyakov, Nikita
Chernikova, Alena
Tabakova, Irina
Gintsburg, Alexandre
author_sort Belyi, Yury
collection PubMed
description BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop new means of specific protection or immunotherapy. MATERIAL AND METHODS: We found that rabbit serum raised against crude concentrated S. aureus liquid culture significantly decreased the development of staphylococcal biofilm in vitro. To discover the corresponding staphylococcal antigen, we used mass-spectrometry and molecular cloning and identified three major immunodominant proteins. They included α-haemolysin, serine proteinase SplB and S. aureus surface protein G, known as adhesin SasG. RESULTS: Although according to literature data, all these proteins represent virulence factors of S. aureus and play diverse and important roles in the pathogenesis of staphylococcal diseases, only SasG can be directly implicated into the biofilm formation because of its surface location on a staphylococcal cell. Indeed, rabbit serum directed against purified recombinant SasG, similar to serum against crude staphylococcal liquid culture, prevented the formation of a biofilm. CONCLUSION: SasG can be considered as a target in an anti-biofilm drug development and a component of the vaccine or immunotherapeutic preparations directed against staphylococcal infections in humans.
format Online
Article
Text
id pubmed-5944129
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-59441292018-05-21 Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development Belyi, Yury Rybolovlev, Ivan Polyakov, Nikita Chernikova, Alena Tabakova, Irina Gintsburg, Alexandre Open Microbiol J Microbiology BACKGROUND: Staphylococcus aureus is a Gram-positive bacterium that causes severe illnesses in the human population. The capacity of S. aureus strains to form biofilms on biotic and abiotic surfaces creates serious problems for treatment of hospital infections and has stimulated efforts to develop new means of specific protection or immunotherapy. MATERIAL AND METHODS: We found that rabbit serum raised against crude concentrated S. aureus liquid culture significantly decreased the development of staphylococcal biofilm in vitro. To discover the corresponding staphylococcal antigen, we used mass-spectrometry and molecular cloning and identified three major immunodominant proteins. They included α-haemolysin, serine proteinase SplB and S. aureus surface protein G, known as adhesin SasG. RESULTS: Although according to literature data, all these proteins represent virulence factors of S. aureus and play diverse and important roles in the pathogenesis of staphylococcal diseases, only SasG can be directly implicated into the biofilm formation because of its surface location on a staphylococcal cell. Indeed, rabbit serum directed against purified recombinant SasG, similar to serum against crude staphylococcal liquid culture, prevented the formation of a biofilm. CONCLUSION: SasG can be considered as a target in an anti-biofilm drug development and a component of the vaccine or immunotherapeutic preparations directed against staphylococcal infections in humans. Bentham Open 2018-04-30 /pmc/articles/PMC5944129/ /pubmed/29785216 http://dx.doi.org/10.2174/1874285801812010094 Text en © 2018 Belyi et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Microbiology
Belyi, Yury
Rybolovlev, Ivan
Polyakov, Nikita
Chernikova, Alena
Tabakova, Irina
Gintsburg, Alexandre
Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title_full Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title_fullStr Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title_full_unstemmed Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title_short Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development
title_sort staphylococcus aureus surface protein g is an immunodominant protein and a possible target in an anti-biofilm drug development
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944129/
https://www.ncbi.nlm.nih.gov/pubmed/29785216
http://dx.doi.org/10.2174/1874285801812010094
work_keys_str_mv AT belyiyury staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment
AT rybolovlevivan staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment
AT polyakovnikita staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment
AT chernikovaalena staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment
AT tabakovairina staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment
AT gintsburgalexandre staphylococcusaureussurfaceproteingisanimmunodominantproteinandapossibletargetinanantibiofilmdrugdevelopment